Bian Zhaoxiang
Professor
Department of Clinical Division
Institute of Integrated Bioinformedicine and Translational Science
Hong Kong
Biography
Name: Bian Zhaoxiang Academic qualifications: 1984.9-1988.7 B. Med Nanjing University of Chinese Medicine, P. R. CHINA 1988.9-1991.7 M. Med. Beijing University of Traditional Chinese Medicine, P. R. CHINA 1991.9-1994.7 Ph.D. Guangzhou University of Traditional Chinese Medicine, P. R. CHINA Previous academic positions held: 1994.7-1995.11 Lecturer Institute of Digestive Diseases Guangzhou University of Traditional Chinese Medicine, P. R. China 1996.4-2000.1 Associate Professor and Physician of Internal Medicine Institute of Digestive Diseases Guangzhou University of Traditional Chinese Medicine, P. R. China. 2000.2-2001.4 Associate Professor and Deputy Academic Registrar Guangzhou University of Traditional Chinese Medicine, P. R. China 2001.5-2010.8 Assistant Professor and Director, Clinical Division School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Present academic position: 2010.9- Professor and Director, Clinical Division School of Chinese Medicine, Hong Kong Baptist University, Hong Kong Previous relevant research work: Research area Mechanism of development of irritable bowel syndrome, inflammatory bowel disease, and colorectal cancer; Therapeutic effects of Traditional Chinese medicine and their mechanism for digestive diseases
Research Interest
Mechanism of development of irritable bowel syndrome, inflammatory bowel disease, and colorectal cancer; Therapeutic effects of Traditional Chinese medicine and their mechanism for digestive diseases
Publications
-
Fu SF, Kun W, Zeng XX, Zhang L, Cheng CW, Song L, Zhong LL, Lin J, Wang YY, Shang HC, Bian ZX. Urgent need to improve the quality of case report in traditional Chinese medicine: Assessment on reporting quality of 3,417 cases. Chinese journal of integrative medicine. 2016 Jun 1;22(6):473-80.
-
Fatima S, Shi X, Lin Z, Chen GQ, Pan XH, Wu JC, Ho JW, Lee NP, Gao H, Zhang G, Lu A. 5â€Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing βâ€catenin. Molecular oncology. 2016 Feb 1;10(2):195-212.
-
Liang C, Guo B, Wu H, Shao N, Li D, Liu J, Dang L, Wang C, Li H, Li S, Lau WK. Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy. Nature medicine. 2015 Mar 1;21(3):288-94.
